These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6687556)

  • 21. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.
    Kappas A; Simionatto CS; Drummond GS; Sassa S; Anderson KE
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):896-900. PubMed ID: 3856238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
    Wong RJ; Vreman HJ; Schulz S; Kalish FS; Pierce NW; Stevenson DK
    J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin.
    Drummond GS; Kappas A
    J Clin Invest; 1984 Jul; 74(1):142-9. PubMed ID: 6547455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of tin protoporphyrin on the excretion rate of carbon monoxide in newborn rats after hematoma formation.
    Posselt AM; Cowan BE; Kwong LK; Vreman HJ; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):650-4. PubMed ID: 3839847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro and in vivo inhibition of intestinal heme oxygenase by tin-protoporphyrin.
    Rosenberg DW; Drummond GS; Kappas A
    Pharmacology; 1989; 39(4):224-9. PubMed ID: 2608721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility.
    Kappas A; Drummond GS; Manola T; Petmezaki S; Valaes T
    Pediatrics; 1988 Apr; 81(4):485-97. PubMed ID: 3281127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
    Drummond GS; Kappas A
    Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory influence of tin-protoporphyrin on gossypol-induced alterations of heme oxygenase activity in male Wistar rats.
    Aneja R; Dass SK; Chandra R
    Eur J Drug Metab Pharmacokinet; 2003; 28(3):237-43. PubMed ID: 14527098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of carbon monoxide excretion rate by tin protoporphyrin.
    Posselt AM; Kwong LK; Vreman HJ; Stevenson DK
    Am J Dis Child; 1986 Feb; 140(2):147-50. PubMed ID: 3753817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.
    Kappas A; Drummond GS; Sardana MK
    J Clin Invest; 1985 Jan; 75(1):302-5. PubMed ID: 3965510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of suppression of the androgenic axis by cobalt-protoporphyrin to its effects on weight loss and hepatic heme oxygenase induction.
    Galbraith RA; Drummond GS; Krey L; Kappas A
    Pharmacology; 1987; 34(5):241-9. PubMed ID: 3615567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia.
    Maines MD; Trakshel GM
    Biochim Biophys Acta; 1992 Jun; 1131(2):166-74. PubMed ID: 1610897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin.
    Kappas A; Drummond GS; Simionatto CS; Anderson KE
    Hepatology; 1984; 4(2):336-41. PubMed ID: 6546735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans.
    Anderson KE; Simionatto CS; Drummond GS; Kappas A
    Clin Pharmacol Ther; 1986 May; 39(5):510-20. PubMed ID: 3698459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.
    Berglund L; Angelin B; Hultcrantz R; Einarsson K; Emtestam L; Drummond G; Kappas A
    Gut; 1990 Aug; 31(8):899-904. PubMed ID: 2387514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tin protoporphyrin inhibits carbon monoxide production in adult mice.
    Milleville GS; Levitt MD; Engel RR
    Pediatr Res; 1985 Jan; 19(1):94-6. PubMed ID: 3838208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical properties of the heme oxygenase inhibitor, Sn-protoporphyrin. Interactions with apomyoglobin and human serum albumin.
    Breslow E; Chandra R; Kappas A
    J Biol Chem; 1986 Mar; 261(7):3135-41. PubMed ID: 3753975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of heme oxygenase inhibitors to the spleen markedly increases their ability to diminish bilirubin production.
    Landaw SA; Drummond GS; Kappas A
    Pediatrics; 1989 Dec; 84(6):1091-6. PubMed ID: 2587139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of heme oxygenase in heme-mediated inhibition of rat brain Na+-K+-ATPase: protection by tin-protoporphyrin.
    Levere RD; Escalante B; Schwartzman ML; Abraham NG
    Neurochem Res; 1989 Sep; 14(9):861-4. PubMed ID: 2556652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.